跳至主要内容
临床试验/NCT05912192
NCT05912192已完成不适用

The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis

National University of Malaysia1 个研究点 分布在 1 个国家目标入组 163 人开始时间: 2022年2月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
163
试验地点
1
主要终点
Change from Baseline in Symptoms Score on Allergic Rhinitis at Week 4

研究概览

简要总结

The aim of this clinical study is to compare the efficacy of Elonide Nasal Spray to Nasonex Nasal Spray and Placebo (non-active ingredient) in the management of allergic rhinitis.

There are two hypotheses of this study:

  1. Elonide nasal spray is same efficacy to Nasonex nasal spray.
  2. Elonide nasal spray is more efficient to placebo.

详细描述

There are several objectives of the study:

  1. To compare the efficacy of Elonide to Nasonex and Placebo in treating allergic rhinitis via Quality of life assessments and nasal airflow improvements.
  2. To compare the efficacy of Elonide to Nasonex and Placebo in treating allergic rhinitis via symptomatics improvement.
  3. To assess the side effect of Nasal spray given.

Patients who meet the criteria to join the study will be randomized in a double-blind manner (patients and investigators). Patients will be given information about the study and consent form, patients will be randomized to 3 treatment group(Elonide, Nasonex, Placebo). Patients will be evaluated before and after treatment in one month time. Patients will be advised to use the nasal spray twice daily.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All adults patients 18 years and above
  • Newly diagnosed mild, moderate to severe, intermittent and persistent allergic rhinitis
  • Positive skin prick test or serum Immunoglobulin E

排除标准

  • Patients who have been on allergic rhinitis treatment
  • Below 18 years old
  • Patients diagnosed with asthma or immunodeficiency diseases
  • Pregnancy
  • Other concomitant rhinology disease
  • Severe deviated nasal septum

研究组 & 干预措施

Elonide Nasal Spray

Experimental

Elonide is generic nasal spray Dose: 50 mcg/dose mometasone furoate 140 sprays per nasal spray One pump for both nostrils twice daily

干预措施: Elonide Nasal Spray (Drug)

Nasonex Nasal Spray

Active Comparator

Nasonex Aqueous Nasal Spray Dose: 50 mcg/dose mometasone furoate 140 sprays per nasal spray The usual recommended dose for prophylaxis and treatment is two sprays (50 micrograms/spray) in each nostril once daily (total dose 200 micrograms) One pump for both nostrils twice daily

干预措施: Nasonex Nasal Spray (Drug)

Normal Saline

Placebo Comparator

Placebo used is 0.9% sodium chloride Dose: 50 mcg/dose of 0.9% sodium chloride One pump for both nostrils twice daily

干预措施: Normal saline (Drug)

结局指标

主要结局

Change from Baseline in Symptoms Score on Allergic Rhinitis at Week 4

时间窗: Baseline and week 4

The Visual Analogue Score (VAS) is a validated, self-reported instrument assessing average scoring of overall allergic rhinitis symptoms in the last 7 days period from treatment date. Possible score range from 0 (no symptoms) to 100 (worst possible symptoms). Maximum number of change from baseline indicate improvement of symptoms. Change= (Baseline score - Week 4 score)

Mean difference from Baseline in Quality of Life Questionnaire on several domains at Week 4

时间窗: Baseline and week 4

Rhinoconjunctivitis Quality of Life Questionnaire (RQOLQ) contains several domains score to access patient quality of life for a 7 days period from treatment date. The domains include activities, sleep, non-hay symptoms, practical problems, nasal symptoms, eye symptoms and emotional. Possible scoring from 0 (not trouble) to 6 (extremely troubled). Change= (Baseline score - Week 4 score)

Change from Baseline in Total Nasal Resistance while normal breathing at Week 4

时间窗: Baseline and week 4

Total Nasal Resistance is performed using Rhinomanometry device that provides a functional measure if pressure during a breathing cycle. Normal values for total nasal resistance is below 0.2 and to 0.3 Pa cm3/s. Worst case will be higher than 0.3 Pa cm3/s indicate nasal obstruction. Change= (Baseline score - Week 4 score)

次要结局

  • Adverse effect of Nasal Spray(Baseline to week 4)

研究者

发起方
National University of Malaysia
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验